AbbVie announced the acquisition of Celsius Therapeutics, Inc., a privately held biotechnology company pioneering new therapies for patients with inflammatory disease. Celsius' lead investigational...
RareCyte, Inc. a Life Sciences company providing advanced Precision Biology platforms including instruments, reagents, software, and services announced the completion of a $20M financing from...
Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, announced that Kite, a Gilead Company, will...
kneat.com, inc., a leader in digitizing and automating validation and quality processes, is pleased to announce that it has signed a partnership agreement with leading...
Daicel Arbor Biosciences is excited to announce the release of the next generation of its myTXTL® kits, for cell-free protein expression, designed to simplify and...
